Linda Maxwell, MD, MBA

Board Member

Linda Maxwell is an Operating Partner at DCVC and an accomplished surgeon, scientist, and innovator, with over 20 years of clinical experience. At DCVC, she leads the firm’s health tech thesis, identifying, investing in, and supporting founders transforming medicine and healthcare to drive outsized impact. Her work is guided by a sharp entrepreneurial instinct, pragmatism, and a commitment to serving the firm, founders, and patients. Before joining DCVC, Linda founded the Biomedical Zone, Canada’s first hospital-embedded biomedical technology incubator. As Executive Director, she personally mentored over 100 medtech and digital health founders, whose companies have improved the lives of more than 67,000 patients globally. Linda has been recognized as one of Canada’s Top 100 Most Powerful Women by the Women’s Executive Network, one of the Top 30 Women Making a Difference in Tech, and one of the Top 100 Accomplished Black Women in Canada. Linda earned a bachelor’s degree with honors in biology from Harvard University, an MD from Yale University, and an MBA from the University of Oxford. She completed her residency and fellowship at the University of Toronto and is double-board certified. Linda also serves on the boards of United Therapeutics (Nasdaq: UTHR) and ImmunityBio (Nasdaq: IBRX), is a certified Independent Corporate Director, and holds a federal appointment with the Public Health Agency of Canada.